Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 21.2% during trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares changed hands during trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Down 10.0 %
The stock has a market cap of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm has a fifty day moving average of C$0.11 and a 200 day moving average of C$0.08.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Why Are Stock Sectors Important to Successful Investing?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Why is the Ex-Dividend Date Significant to Investors?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- The How and Why of Investing in Gold Stocks
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
